Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Detection of Endometrial Cancer Through Risk Modelling
The University of British Columbia sponsors a study on detecting endometrial cancer using risk modelling. The trial status is recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating IACS-6274 with or without Bevacizumab and Paclitaxel in adults with advanced solid tumors; the study is cu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating oral MOMA-341 in adults with advanced or metastatic solid tumors, including endometrial, colorectal, and gastric ca…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
Clinical trial update describing an infertility survey for reproductive-age women with breast cancer and gynecologic cancers; the study is c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of XMT-1660 in Participants With Solid Tumors [Phase 1]
Phase 1 study of XMT-1660 in participants with solid tumors is currently recruiting. The trial lists indications including triple-negative b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
A Mayo Clinic-sponsored trial evaluates the acceptability of using DNA markers in vaginal fluid to detect endometrial cancer; the study stat…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers [Phase 2]
Phase 2 trial update for relacorilant in combination with different regimens in gynecologic cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER [Phase 2]
This Phase 2 trial update notes ongoing recruitment for adjuvant therapies targeting POLE-mutated and p53-wildtype/NSMP early-stage endometr…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
A Mayo Clinic-backed clinical trial is investigating molecular and ctDNA characterization in high-risk endometrial cancer to improve underst…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers [Phase 1, Phase 2]
Clinical trial update exploring addition of the AKT inhibitor ipatasertib to megestrol acetate for recurrent or metastatic endometrial cance…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer [Phase 3]
This Phase 3 trial is evaluating adding pembrolizumab to standard radiation therapy for newly diagnosed early-stage high-intermediate risk e…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4 [Phase 2]
MITO END-4 is a Phase 2 trial evaluating Inavolisib for PIK3CA-mutated advanced endometrial cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer [Phase 2]
This clinical trial update reports a phase 2 study of giredestrant in participants with grade 1 endometrial cancer; the trial is currently a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer [Phase 1]
Phase 1 clinical trial assessing different dosing amounts of the drug combination M1774 and ZEN-3694 for recurrent ovarian and endometrial c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) [Phase 3]
Phase 3 trial evaluating Puxitatug Samrotecan (AZD8205) as monotherapy versus chemotherapy in B7-H4-selected endometrial cancer is currently…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers [Phase 1]
This is a Phase 1 clinical trial update evaluating the combination of APG-1252 (Pelcitoclax) and cobimetinib in recurrent and advanced ovari…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of a Weight Loss Intervention in People With Endometrial Cancer [EARLY_Phase 1]
This entry reports an ongoing EARLY_PHASE1 clinical trial at Memorial Sloan Kettering Cancer Center to evaluate a weight loss intervention i…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors [Phase 2]
A Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-expressing tumors, including bladder, biliary tract, cervical, …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer [Phase 1, Phase 2]
This clinical trial is investigating a combination therapy of pembrolizumab, lenvatinib, and the IL-15 superagonist N-803 with a HER2-target…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors [Phase 1, Phase 2]
This clinical trials update notes ongoing Phase 1/2 studies of EIK1005, a Werner helicase inhibitor, as monotherapy and in combination with …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer [Phase 3]
This is a Phase III clinical trial evaluating trastuzumab deruxtecan with either rilvegostomig or pembrolizumab as first-line therapy for HE…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Plant-Based Nutrition for Breast or Endometrial Cancer [NA]
A clinical trial investigating plant-based nutrition as an intervention for metastatic breast cancer and stage IV endometrial cancer is list…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) [Phase 1, Phase 2]
Genmab is conducting a Phase 1/2 clinical trial of Rinatabart Sesutecan for multiple advanced solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…